Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

United Therapeutics Corp (NASDAQ:UTHR)

131.69
Delayed Data
As of Dec 09
 -0.18 / -0.14%
Today’s Change
97.52
Today|||52-Week Range
164.04
-15.91%
Year-to-Date

Today’s Trading

Previous close131.87
Today’s open132.72
Day’s range131.45 - 136.49
Volume400,878
Average volume (3 months)546,818
Market cap$5.6B
Dividend yield--
Data as of 4:00pm ET, 12/09/2016

Growth & Valuation

Earnings growth (last year)+102.55%
Earnings growth (this year)+24.03%
Earnings growth (next 5 years)+0.50%
Revenue growth (last year)+13.76%
P/E ratio8.8
Price/Sales5.47
Price/Book3.79

Competitors

 Today’s
change
Today’s
% change
MNKMallinckrodt Plc+0.25+0.48%
IONSIonis Pharmaceutical...-0.99-2.13%
VRXValeant Pharmaceutic...+0.02+0.13%
OPKOPKO Health Inc+0.16+1.48%
Data as of 4:02pm ET, 12/09/2016

Financials

Next reporting dateFebruary 28, 2017
EPS forecast (this quarter)$3.65
Annual revenue (last year)$1.5B
Annual profit (last year)$651.6M
Net profit margin44.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Martine A. Rothblatt
President &
Chief Operating Officer
Michael Benkowitz
Corporate headquarters
Silver Spring, Maryland

Forecasts


Search for Jobs